Improving Access to Safe Medicines Act of 2022
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Sep 21, 2022)
Improving Access to Safe Medicines Act of 2022
This bill requires the Drug Enforcement Administration to issue a proposed rule to remove a drug from scheduling under the Controlled Substances Act within 180 days of a recommendation from the Food and Drug Administration to do so.
What just happenedNov 1, 2022
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Who’s behind it
- Introduced in HouseSep 21, 2022
- Nov 1, 2022Committee
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Crime and Federal Government Surveillance Subcommittee - Sep 22, 2022Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Sep 21, 2022IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Judiciary Committee - Sep 21, 2022IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Sep 21, 2022IntroReferralIntro-H
Introduced in House
- Sep 21, 2022IntroReferral1000
Introduced in House